Clinical Study
A Prospective Study of Platelet-Rich Plasma as Biological Augmentation for Acute Achilles Tendon Rupture Repair
Table 5
Percentage of dorsiflexion strength (%).
| | 3 months | 6 months | 1 year | 2 years |
| 60°/s | | | | | Control | 65.6 ± 6.6 | 86.6 ± 6.6 | 95.5 ± 2.5 | 95.7 ± 2.4 | PRP | 69.7 ± 4.0 | 90.6 ± 6.0 | 96.1 ± 2.6 | 96.2 ± 1.9 | | 2.2 | 1.8 | 0.6 | 0.7 | | 0.035 | 0.072 | 0.52 | 0.46 | 120°/s | | | | | Control | 63.0 ± 5.3 | 83.4 ± 5.9 | 93.1 ± 3.0 | 94.7 ± 2.6 | PRP | 67.9 ± 4.4 | 84.9 ± 5.9 | 94.0 ± 3.3 | 94.4 ± 3.2 | | 3.2 | 3.1 | 0.2 | 0.1 | | 0.006 | 0.44 | 0.39 | 0.74 | 240°/s | | | | | Control | 61.4 ± 3.2 | 80.45 ± 4.4 | 94.9 ± 2.6 | 95.0 ± 3.1 | PRP | 67.9 ± 4.1 | 83.5 ± 5.0 | 94.7 ± 3.5 | 95.6 ± 2.8 | | 5.3 | 1.9 | 0.2 | 0.5 | | <0.001 | 0.061 | 0.83 | 0.61 |
|
|